Literature DB >> 11245810

Biotinylated m4-toxin demonstrates more M4 muscarinic receptor protein on direct than indirect striatal projection neurons.

M P Santiago1, L T Potter.   

Abstract

The striatum has nearly equal numbers of striatonigral and striatopallidal projection neurons. All are GABAergic and inhibitory, but they lie in separate neuronal circuits ('direct' and 'indirect', respectively) that appear to exert opposite effects on movement. Methods are needed to evaluate the function of each circuit. A potential way to control striatonigral neurons selectively is via M4 muscarinic receptors. The striatum has many more M4 receptors than other tissues, they are located on approximately half of all projection neurons, and mRNA for M4 receptors is prevalent only in striatonigral neurons. In order to more rigorously compare the distribution of M4 receptors on rat neurons in these pathways a toxin that binds with very high specificity to M4 receptors (m4-toxin) was biotinylated for use as a selective probe for M4 receptor protein. Pooled biotin-toxin complexes were found to retain high M4-specificity and affinity. Neurons were first labeled by retrograde transport of fluorescent microbeads (FluoSpheres) injected into the substantia nigra and globus pallidus. Coincident labeling of only 4% of the cells confirmed the validity of the retrograde labeling technique. Labeled neurons were probed for M4 receptor protein using biotinylated m4-toxin and fluorescent avidin. M4 receptors were found on 14% of indirect and 86% of direct neurons. It may be concluded that there is a relative abundance of M4 receptors controlling the direct pathway. This work supports the hypothesis that M4-selective drugs will prove useful to control the function of striatonigral neurons in the direct projection pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245810     DOI: 10.1016/s0006-8993(00)03170-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  31 in total

1.  CaMKIIα, a modulator of M4 muscarinic acetylcholine receptors.

Authors:  Ming-Lei Guo; Zhenguo Liu; Xiang-Ping Chu; Li-Min Mao; John Q Wang
Journal:  Commun Integr Biol       Date:  2010-09

2.  Effects of dopamine D1-like and D2-like antagonists on cocaine discrimination in muscarinic receptor knockout mice.

Authors:  Morgane Thomsen; Simon Barak Caine
Journal:  Eur J Pharmacol       Date:  2016-02-11       Impact factor: 4.432

3.  Dopaminergic and cholinergic regulation of Fyn tyrosine kinase phosphorylation in the rat striatum in vivo.

Authors:  Li-Min Mao; John Q Wang
Journal:  Neuropharmacology       Date:  2015-08-13       Impact factor: 5.250

4.  M1 muscarinic receptors contribute to, whereas M4 receptors inhibit, dopamine D1 receptor-induced [3H]-cyclic AMP accumulation in rat striatal slices.

Authors:  Enrique Sánchez-Lemus; José-Antonio Arias-Montaño
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

5.  Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching.

Authors:  Martha F McCool; Sima Patel; Ravi Talati; Michael E Ragozzino
Journal:  Neurobiol Learn Mem       Date:  2007-08-20       Impact factor: 2.877

6.  A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.

Authors:  Douglas J Sheffler; Richard Williams; Thomas M Bridges; Zixiu Xiang; Alexander S Kane; Nellie E Byun; Satyawan Jadhav; Mathew M Mock; Fang Zheng; L Michelle Lewis; Carrie K Jones; Colleen M Niswender; Charles D Weaver; Craig W Lindsley; P Jeffrey Conn
Journal:  Mol Pharmacol       Date:  2009-04-30       Impact factor: 4.436

Review 7.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

8.  The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide.

Authors:  Surabi Veeraragavan; Nghiem Bui; Jennie R Perkins; Lisa A Yuva-Paylor; Richard Paylor
Journal:  Behav Neurosci       Date:  2011-10       Impact factor: 1.912

9.  Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.

Authors:  Samira Ztaou; Nicolas Maurice; Jeremy Camon; Gaëlle Guiraudie-Capraz; Lydia Kerkerian-Le Goff; Corinne Beurrier; Martine Liberge; Marianne Amalric
Journal:  J Neurosci       Date:  2016-08-31       Impact factor: 6.167

10.  Regulation of synaptic MAPK/ERK phosphorylation in the rat striatum and medial prefrontal cortex by dopamine and muscarinic acetylcholine receptors.

Authors:  Bing Xue; Li-Min Mao; Dao-Zhong Jin; John Q Wang
Journal:  J Neurosci Res       Date:  2015-07-08       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.